Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acrobator Ventures is an active, Amsterdam-based venture capital fund focused on early-stage (pre-seed, seed) investments in B2B SaaS, AI/ML, data-driven, cybersecurity, fintech, synthetic media, and infrastructure startups, primarily from the Dutch, Baltic, and Central & Eastern European (CEE) regions, with the goal of bridging Eastern European startups to Western markets[1][2][5]. The fund is operator-led, emphasizes founder coaching, and provides ongoing support from pre-seed through IPO, often leading investment rounds with checks ranging from $200k to $1.25 million[1][2][5].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acrobator Ventures.